Hemophilia A With Inhibitor
Rare Disease·MeSH: Hemophilia A
Prevalence
12.0 / 100K
Incidence
20.0 / 100K/yr
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 1/Phase 2(1)
Frequently asked questions
How many drugs are in development for Hemophilia A With Inhibitor?
BioSniper tracks 1 drug in development for Hemophilia A With Inhibitor across 1 company.
How many clinical trials target Hemophilia A With Inhibitor?
There are 1 clinical trial targeting Hemophilia A With Inhibitor tracked by BioSniper.
What is the prevalence of Hemophilia A With Inhibitor?
The estimated prevalence of Hemophilia A With Inhibitor is approximately 12.0 per 100,000 population.
Deep-dive into Hemophilia A With Inhibitor
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis